High-Throughput Antibody Profiling Identifies Targets of Protective Immunity against P. falciparum Malaria in Thailand
Open Access
- 18 August 2023
- journal article
- research article
- Published by MDPI AG in Biomolecules
- Vol. 13 (8) , 1267
Abstract
Malaria poses a significant global health challenge, resulting in approximately 600,000 deaths each year. Individuals living in regions with endemic malaria have the potential to develop partial immunity, thanks in part to the presence of anti-plasmodium antibodies. As efforts are made to optimize and implement strategies to reduce malaria transmission and ultimately eliminate the disease, it is crucial to understand how these interventions impact naturally acquired protective immunity. To shed light on this, our study focused on assessing antibody responses to a carefully curated library of P. falciparum recombinant proteins (n = 691) using samples collected from individuals residing in a low-malaria-transmission region of Thailand. We conducted the antibody assays using the AlphaScreen system, a high-throughput homogeneous proximity-based bead assay that detects protein interactions. We observed that out of the 691 variable surface and merozoite stage proteins included in the library, antibodies to 268 antigens significantly correlated with the absence of symptomatic malaria in an univariate analysis. Notably, the most prominent antigens identified were P. falciparum erythrocyte membrane protein 1 (PfEMP1) domains. These results align with our previous research conducted in Uganda, suggesting that similar antigens like PfEMP1s might play a pivotal role in determining infection outcomes in diverse populations. To further our understanding, it remains critical to conduct functional characterization of these identified proteins, exploring their potential as correlates of protection or as targets for vaccine development.Keywords
Funding Information
- Japan Society for the Promotion of Science (JP21H02724, JP21KK0138, JP22wm0325038h0002, JP22wm0225020h0001, 5TMU45H1, TMA2020CDF-3203)
- Japan Agency for Medical Research and Development (JP21H02724, JP21KK0138, JP22wm0325038h0002, JP22wm0225020h0001, 5TMU45H1, TMA2020CDF-3203)
- Thailand Research Fund (JP21H02724, JP21KK0138, JP22wm0325038h0002, JP22wm0225020h0001, 5TMU45H1, TMA2020CDF-3203)
- European Commission (JP21H02724, JP21KK0138, JP22wm0325038h0002, JP22wm0225020h0001, 5TMU45H1, TMA2020CDF-3203)
This publication has 40 references indexed in Scilit:
- A cell-free approach to accelerate the study of protein–protein interactions in vitroInterface Focus, 2013
- Plasmodium vivax: comparison of immunogenicity among proteins expressed in the cell-free systems of Escherichia coli and wheat germ by suspension array assaysMalaria Journal, 2011
- Simple Screening Method for Autoantigen Proteins Using the N-Terminal Biotinylated Protein Library Produced by Wheat Cell-Free SynthesisJournal of Proteome Research, 2010
- A prospective analysis of the Ab response to Plasmodium falciparum before and after a malaria season by protein microarrayProceedings of the National Academy of Sciences, 2010
- The Relationship between Anti-merozoite Antibodies and Incidence of Plasmodium falciparum Malaria: A Systematic Review and Meta-analysisPLOS Medicine, 2010
- High Throughput Functional Assays of the Variant Antigen PfEMP1 Reveal a Single Domain in the 3D7 Plasmodium falciparum Genome that Binds ICAM1 with High Affinity and Is Targeted by Naturally Acquired Neutralizing AntibodiesPLOS Pathogens, 2009
- Acquired Immunity to MalariaClinical Microbiology Reviews, 2009
- Profiling humoral immune responses to P. falciparum infection with protein microarraysProteomics, 2008
- Wheat Germ Cell-Free System-Based Production of Malaria Proteins for Discovery of Novel Vaccine CandidatesInfection and Immunity, 2008
- The Use of AlphaScreen Technology in HTS: Current StatusCurrent Chemical Genomics, 2008